| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MOBQ | Common Stock | Options Exercise | $300,000 | 96,100 | 07 Nov 2023 | Common Stock | 428,571 | $0.7000 | Direct | F2, F3 | |||
| transaction | MOBQ | Preferred Stock | Award | +300,789 | +11% | 3,103,990 | 07 Nov 2023 | Common Stock | 3,007,890 | $5.00 | Direct | F1, F3 |
| Id | Content |
|---|---|
| F1 | Not applicable. |
| F2 | The derivative securities listed in Table II are derivative securities owned directly by Dr. Salkind and his wife and by the trust. Salkind has the right to convert $300,000 loan into common stock at $.70 per share or into the terms of a financing completed before November 30, 2023. |
| F3 | Salkind and his trust invested an additional $1,200,000 plus converted the $300,000 principal loan plus interest of $3,495 (totaling$1,503,495) into shares of Series G Preferred Stock, convertible at holders option at any time into common stock at an effective price of $.50 per share. |